📰 Brain Communications News
Brain Communications News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Brain Communications. Real-time updates on events, politics, business and more.
June 11, 2024
The genetic disease Huntington's not only affects nerve cells in the brain but also has widespread effects on microscopic blood vessels according to
June 11, 2024
News and commentary from the world of neurology and neuroscience
June 10, 2024
The genetic disease Huntington's not only affects nerve cells in the brain but also has widespread effects on microscopic blood vessels according to
April 30, 2024
News and commentary from the world of neurology and neuroscience
April 8, 2024
Recent investigations of speech-related brain stimulation may point to how we plan what we say before we say it.
April 4, 2024
In a pioneering move, researchers at The Florey Institute have developed a novel method utilizing mRNA technology to directly target the tau protein, which plays a critical role in the development of Alzheimers disease and other dementia-related conditions. This innovative approach marks the first time mRNA, widely recognized for its role in COVID-19 vaccines, has been applied to Alzheimers disease, positioning The Florey as a leader in mRNA research.
April 3, 2024
Different parts of the brain may use different processes for preparing speech, according to a recent study by researchers from NYU’s Grossman School of Medicine. Researchers measured the time between stimulation of distinct areas of the brain and pauses in speech, and said that variations in the pauses indicated differences in speech preparation processes. Over...
April 2, 2024
Get latest articles and stories on Science at LatestLY. Researchers at The Florey have created a method using mRNA technology to specifically target the harmful protein tau, which accumulates in dementia patients suffering from Alzheimer's disease and other conditions. Science News | Study Finds How MRNA Used to Target Alzheimer's Disease.
March 29, 2024
Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer's disease and other dementias.
March 29, 2024
Investigators found that mRNA technology for the delivery of antibody therapeutics were used to target tau in Alzheimer disease and can be applied to other tau targets.